FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gemifloxacin Mesylate (Factive) Tablets
Status: Currently in Shortage
»Date first posted: 05/27/2015
»Therapeutic Categories: Anti-Infective

Expand all

LG Chem, Ltd. (Reverified 04/27/2017)

Company Contact Information:
866-686-6174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
320mg, 7 Tablets in 1 Blister Pack (NDC 44004-321-07) Estimated recovery to be determined. License to manufacture and distribute FACTIVE is under legal dispute. Other
320mg, 5 Tablets in 1 Blister Pack (NDC 44004-321-05) Estimated recovery to be determined. License to manufacture and distribute FACTIVE is under legal dispute. Other

OrchidPharma, Inc. (New 03/17/2017)

Company Contact Information:
609-759-1777; email: sales@orchidpharma.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
320 mg, 5 Tablets in one Blister Pack, One Blister Pack (NDC 42043-310-95) Estimated recovery: 4Q 2017 Other
320 mg, 7 Tablets in one Blister Pack, One Blister Pack (NDC 42043-310-97) Estimated recovery: 4Q 2017 Other
320 mg, 500 tablet Bottle (NDC 42043-310-05) Estimated recovery: 4Q 2017 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English